Inclusion Body Myositis clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for

  • A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

    open to eligible people ages 40 years and up

    A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis

    at UC Irvine

  • Sporadic Inclusion Body Myositis Natural History Study

    open to eligible people ages 40 years and up

    This is a prospective natural history study on patients with clinically defined sIBM. Participants will be assessed every 6 months over two years (five visits total). We will include 150 participants, enrolled across 13 sites, with sporadic IBM, diagnosed according to established criteria.

    at UC Irvine UCLA

Our lead scientists for Inclusion Body Myositis research studies include .

Last updated: